Reinhard Hohlfeld
Researcher Next ID · RN-029745
Researcher · Medicine
Munich Cluster for Systems Neurology
Munich, Slovakia
- Works count
- 551
- Citation count
- 35,519
- H-index
- 99
- i10-index
- 280
Research interests
Publications
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
Cell · 2022 · 10.1016/j.cell.2022.08.021
Role of B Cells in Multiple Sclerosis and Related Disorders
Annals of Neurology · 2020 · 10.1002/ana.25927
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology · 2018 · 10.1016/s1474-4422(18)30069-3
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Proceedings of the National Academy of Sciences · 2017 · https://doi.org/10.1073/pnas.1711233114
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
Journal of Neurology · 2016 · 10.1007/s00415-016-8045-z
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Nature Communications · 2015 · 10.1038/ncomms8333
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Neurology · 2011 · 10.1212/wnl.0b013e318228c0b1
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
Neurology · 2011 · 10.1212/wnl.0b013e3182152881
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0909494
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Brain · 2009 · https://doi.org/10.1093/brain/awp300
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Nature Clinical Practice Neurology · 2008 · 10.1038/ncpneuro0764
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
Nature Medicine · 2008 · 10.1038/nm1714
Neurofascin as a novel target for autoantibody-mediated axonal injury
The Journal of Experimental Medicine · 2007 · 10.1084/jem.20071053
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
Annals of Neurology · 2006 · 10.1002/ana.20890
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
The Journal of Experimental Medicine · 2005 · https://doi.org/10.1084/jem.20041674
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Brain · 2005 · 10.1093/brain/awh680
Multiple sclerosis: Brain-infiltrating CD8 + T cells persist as clonal expansions in the cerebrospinal fluid and blood
Proceedings of the National Academy of Sciences · 2004 · 10.1073/pnas.0308689100
Polymyositis and dermatomyositis
The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)14368-1
BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?
Brain · 2002 · 10.1093/brain/awf015
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
The Journal of Experimental Medicine · 2000 · 10.1084/jem.192.3.393
Multiple sclerosis: Comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.97.13.7452
Multiple sclerosis
Neurology · 1999 · 10.1212/wnl.53.8.1622
Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?
The Journal of Experimental Medicine · 1999 · 10.1084/jem.189.5.865
Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
Brain · 1997 · 10.1093/brain/120.5.865
Polymyositis and Dermatomyositis
Neurocritical Care · 1994 · 10.1007/978-3-642-87602-8_72
Current projects
No projects listed.